(PPC) Pilgrims Pride - Overview
Sector: Consumer Defensive | Industry: Packaged Foods | Exchange: NASDAQ (USA) | Market Cap: 8.723m USD | Total Return: -18.9% in 12m
Avg Trading Vol: 34.8M USD
Peers RS (IBD): 44.9
EPS Trend: 22.7%
Qual. Beats: 0
Rev. Trend: 56.7%
Qual. Beats: 1
Pilgrims Pride Corporation (PPC) is a protein producer operating in the United States, Europe, and Mexico. The company processes and distributes fresh, frozen, and value-added chicken and pork products. This includes both primary cuts and prepared items like nuggets and sausages. Meat processing is a capital-intensive industry.
PPC also offers plant-based protein options, ready-to-eat meals, and other multi-protein frozen foods. Their product portfolio extends to lamb and vegetarian foods. The company utilizes a multi-brand strategy, including Pilgrims, Moy Park, and Richmond. Foodservice and retail are key distribution channels for the company.
Founded in 1946, PPC is headquartered in Greeley, Colorado, and operates as a subsidiary of JBS S.A. Vertical integration is common in the poultry industry, from feed production to processing.
Further research on ValueRay can provide detailed financial metrics and competitive analysis for PPC.
- Chicken and pork prices directly impact revenue
- Feed costs, especially corn and soy, influence profitability
- Disease outbreaks in livestock disrupt supply and raise costs
- Regulatory changes in food safety affect production and sales
- Consumer demand for protein products drives sales volume
| Net Income: 1.08b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -7.83 > 1.0 |
| NWC/Revenue: 7.28% < 20% (prev 14.36%; Δ -7.08% < -1%) |
| CFO/TA 0.13 > 3% & CFO 1.37b > Net Income 1.08b |
| Net Debt (2.71b) to EBITDA (2.12b): 1.28 < 3 |
| Current Ratio: 1.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (238.4m) vs 12m ago 0.16% < -2% |
| Gross Margin: 12.75% > 18% (prev 0.13%; Δ 1.26k% > 0.5%) |
| Asset Turnover: 176.2% > 50% (prev 167.9%; Δ 8.35% > 0%) |
| Interest Coverage Ratio: 10.31 > 6 (EBITDA TTM 2.12b / Interest Expense TTM 161.4m) |
| A: 0.13 (Total Current Assets 4.24b - Total Current Liabilities 2.89b) / Total Assets 10.34b |
| B: 0.22 (Retained Earnings 2.25b / Total Assets 10.34b) |
| C: 0.16 (EBIT TTM 1.66b / Avg Total Assets 10.50b) |
| D: 0.33 (Book Value of Equity 2.20b / Total Liabilities 6.65b) |
| Altman-Z'' Score: 2.97 = A |
| DSRI: 1.15 (Receivables 1.28b/1.08b, Revenue 18.50b/17.88b) |
| GMI: 1.01 (GM 12.75% / 12.94%) |
| AQI: 1.12 (AQ_t 0.22 / AQ_t-1 0.20) |
| SGI: 1.03 (Revenue 18.50b / 17.88b) |
| TATA: -0.03 (NI 1.08b - CFO 1.37b) / TA 10.34b) |
| Beneish M-Score: -2.83 (Cap -4..+1) = A |
Over the past week, the price has changed by +7.06%, over one month by -13.25%, over three months by -5.60% and over the past year by -18.92%.
- StrongBuy: 1
- Buy: 0
- Hold: 7
- Sell: 1
- StrongSell: 0
| ISSUER | TARGET | UP/DOWN |
|---|---|---|
| Wallstreet Target Price | 44.1 | 17.9% |
| Analysts Target Price | 44.1 | 17.9% |
P/E Forward = 7.758
P/S = 0.4716
P/B = 2.2741
P/EG = 0.4882
Revenue TTM = 18.50b USD
EBIT TTM = 1.66b USD
EBITDA TTM = 2.12b USD
Long Term Debt = 3.09b USD (from longTermDebt, last quarter)
Short Term Debt = 60.6m USD (from shortTermDebt, last quarter)
Debt = 3.35b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.71b USD (from netDebt column, last quarter)
Enterprise Value = 11.44b USD (8.72b + Debt 3.35b - CCE 640.2m)
Interest Coverage Ratio = 10.31 (Ebit TTM 1.66b / Interest Expense TTM 161.4m)
EV/FCF = 17.31x (Enterprise Value 11.44b / FCF TTM 660.6m)
FCF Yield = 5.78% (FCF TTM 660.6m / Enterprise Value 11.44b)
FCF Margin = 3.57% (FCF TTM 660.6m / Revenue TTM 18.50b)
Net Margin = 5.85% (Net Income TTM 1.08b / Revenue TTM 18.50b)
Gross Margin = 12.75% ((Revenue TTM 18.50b - Cost of Revenue TTM 16.14b) / Revenue TTM)
Gross Margin QoQ = 9.49% (prev 13.85%)
Tobins Q-Ratio = 1.11 (Enterprise Value 11.44b / Total Assets 10.34b)
Interest Expense / Debt = 1.16% (Interest Expense 39.0m / Debt 3.35b)
Taxrate = 49.68% (86.8m / 174.7m)
NOPAT = 837.1m (EBIT 1.66b * (1 - 49.68%))
Current Ratio = 1.47 (Total Current Assets 4.24b / Total Current Liabilities 2.89b)
Debt / Equity = 0.91 (Debt 3.35b / totalStockholderEquity, last quarter 3.68b)
Debt / EBITDA = 1.28 (Net Debt 2.71b / EBITDA 2.12b)
Debt / FCF = 4.11 (Net Debt 2.71b / FCF TTM 660.6m)
Total Stockholder Equity = 3.52b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.31% (Net Income 1.08b / Total Assets 10.34b)
RoE = 30.72% (Net Income TTM 1.08b / Total Stockholder Equity 3.52b)
RoCE = 25.14% (EBIT 1.66b / Capital Employed (Equity 3.52b + L.T.Debt 3.09b))
RoIC = 12.59% (NOPAT 837.1m / Invested Capital 6.65b)
WACC = 3.90% (E(8.72b)/V(12.08b) * Re(5.17%) + D(3.35b)/V(12.08b) * Rd(1.16%) * (1-Tc(0.50)))
Discount Rate = 5.17% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 0.21%
[DCF] Terminal Value 80.82% ; FCFF base≈1.00b ; Y1≈657.8m ; Y5≈300.8m
[DCF] Fair Price = 28.78 (EV 9.55b - Net Debt 2.71b = Equity 6.84b / Shares 237.5m; r=6.0% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 22.70 | EPS CAGR: -29.15% | SUE: -4.0 | # QB: 0
Revenue Correlation: 56.66 | Revenue CAGR: 1.70% | SUE: 0.99 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.31 | Chg7d=-0.025 | Chg30d=-0.025 | Revisions Net=+2 | Analysts=4
EPS current Year (2026-12-31): EPS=4.21 | Chg7d=-0.045 | Chg30d=-0.114 | Revisions Net=-1 | Growth EPS=-18.6% | Growth Revenue=+1.5%
EPS next Year (2027-12-31): EPS=4.06 | Chg7d=-0.014 | Chg30d=-0.079 | Revisions Net=-1 | Growth EPS=-3.5% | Growth Revenue=+1.3%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -4.4% (Discount Rate 7.9% - Earnings Yield 12.4%)
[Growth] Growth Spread = +4.3% (Analyst -0.1% - Implied -4.4%)